Search: onr:"swepub:oai:DiVA.org:uu-128315" >
The influence of Bz...
-
Tolmachev, VladimirUppsala universitet,Institutionen för medicinska vetenskaper
(author)
The influence of Bz-DOTA and CHX-AaEuro(3)-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules : implications for In-114m-mediated targeting therapy
- Article/chapterEnglish2009
Publisher, publication year, extent ...
-
2009-05-09
-
Springer Science and Business Media LLC,2009
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-128315
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-128315URI
-
https://doi.org/10.1007/s00259-009-1134-9DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Affibody molecules represent a novel class of high-affinity agents for radionuclide tumour targeting. Fusion of the Affibody molecules with an albumin-binding domain (ABD) enables modification of the blood kinetics of the Affibody molecules and reduction of the renal dose. Lu-177-CHX-AaEuro(3)-DTPA-ABD-(Z(HER2:342))(2), an anti-HER2 Affibody molecule-ABD fusion protein has earlier demonstrated promising results in treatment of HER2-expressing micro-xenografts in mice. The use of the in vivo generator In-114m/In-114 as a label for ABD-fused Affibody molecules would create preconditions for efficient treatment of both micrometastases (due to conversion and Auger electrons of In-114m) and bulky tumours (due to high-energy beta particles from the daughter nuclide In-114). The goal of this study was to investigate if different chelators influence the biodistribution of ABD-(Z(HER2:342))(2) and to find an optimal chelator for attachment of In-114m to the Affibody molecule-ABD fusion protein. Isothiocyanate derivatives of Bz-DOTA and CHX-AaEuro(3)-DTPA were coupled to ABD-(Z(HER2:342))(2). The cellular processing of both conjugates was studied in vitro. The influence of chelators on the biodistribution was investigated in mice using double isotope (In-114m and In-111) labelling. The apparent affinity of CHX-AaEuro(3)-DTPA-ABD-(Z(HER2:342))(2) and Bz-DOTA-ABD-(Z(HER2:342))(2) to the extracellular domain of HER2 was similar, 13.5 and 15.0 pM, respectively. It was found that both conjugates were internalized by SKOV-3 cells. The use of CHX-AaEuro(3)-DTPA provided better cellular retention of the radioactivity, better tumour accumulation of radioactivity and better tumour to organ dose ratios than Bz-DOTA-ABD-(Z(HER2:342))(2). CHX-AaEuro(3)-DTPA is more suitable for In-114m labelling of Affibody molecule-ABD fusion proteins for radionuclide therapy.
Subject headings and genre
-
Affibody molecule
-
In-114m
-
Biodistribution
-
Radionuclide therapy
-
Albumin-binding domain
-
MEDICINE
-
MEDICIN
Added entries (persons, corporate bodies, meetings, titles ...)
-
Wallberg, Helena
(author)
-
Andersson, KarlUppsala universitet,Enheten för biomedicinsk strålningsvetenskap
(author)
-
Wennborg, Anders
(author)
-
Lundqvist, HansUppsala universitet,Enheten för biomedicinsk strålningsvetenskap(Swepub:uu)hanslund
(author)
-
Orlova, AnnaUppsala universitet,Enheten för biomedicinsk strålningsvetenskap(Swepub:uu)annaorlo
(author)
-
Uppsala universitetInstitutionen för medicinska vetenskaper
(creator_code:org_t)
Related titles
-
In:European Journal of Nuclear Medicine and Molecular Imaging: Springer Science and Business Media LLC36:9, s. 1460-14681619-70701619-7089
Internet link
Find in a library
To the university's database